A study on 452 treatment-naïve women with breast cancer explored the prognostic value of troponins I, T, and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) to predict baseline susceptibility to trastuzumab-related cardiac dysfunction (11). Here, NPPB is linked to breast carcinoma.